Our Team
Our R&D labs are located on the University of Colorado Anschutz Medical Campus
Scientific Leadership Since 1968
At Pathways Bioscience we believe that supporting the body’s own cell protection mechanisms is a crucial way to avoid or overcome health problems. We are focused on the development and commercialization of new dietary supplement and pharmaceutical products that target the Nrf2 cell signaling pathway and influence cytoprotective mechanisms using Nrf2.0® technology.
Our experienced team at Pathways Bioscience is led by Dr. Joe M. McCord (PhD in Biochemistry), who co-discovered the superoxide dismutase enzyme that launched the whole field of redox biology; Dr. Brooks M. Hybertson (MBA, PhD in Analytical Chemistry) who has over 25 years of experience leading R&D pertaining to oxidative stress, the Nrf2 transcription factor, and the development of new pharmaceutical and dietary supplement agents; Dr. Alan Gao (MBA, PhD in Molecular Biology), who is an expert in genomics and the measurement and interpretation of gene expression; Mr. Swapan Bose, a skilled research scientist who has assisted Dr. McCord on his laboratory projects for over 3 decades, and Mr. Mike Lu, who brings financial and strategic expertise to Pathways Bioscience based on his prior experiences as a mutual fund analyst and manager.
Dr. Joe McCord
Founder
Dr. McCord was a founder and first elected President of the Oxygen Society, now called the Society for Redox Biology and Medicine (SFRBM). He has published 200 scientific studies, reviews, and presentations that have now been cited nearly 38,000 times by other scientists. For nearly two decades he has focused on the mechanisms of activation of the Nrf2 transcription factor and the two thousand human genes it regulates.
Dr. Brooks Hybertson
President/CEO
Brooks earned his BA (Chemistry) from St. Olaf College in 1985 and PhD (Analytical Chemistry) from the University of Colorado, Boulder in 1992. He received postdoctoral training at the Webb-Waring Institute for Biomedical Research in Denver prior to joining the University of Colorado School of Medicine faculty. He earned his MBA from the Leeds School of Business at the University of Colorado, Boulder in 2004. He is an author on more than 40 peer-reviewed journal articles and book chapters, and is an inventor on a dozen issued patents.
Dr. Alan Gao
Chief Operating Officer
Dr. Gao’s academic journey includes postdoctoral training in Dr. Joe McCord’s lab, where he focused on genetic engineering of superoxide dismutase enzymes and their roles in oxidative stress and aging. Presently, his research delves into the molecular mechanisms of aging, inflammation, and COVID, employing genome-wide strategies. He is also actively involved in developing new dietary supplements and pharmaceutical products targeting the Nrf2 cell signaling pathway, leveraging Nrf2.0® Technology.
Swapan Bose, B Pharm
Lab Manager
